[Deficient prevention and late treatment of diabetic retinopathy in Mexico].
暂无分享,去创建一个
René A Cervantes-Castañeda | Rufino Menchaca-Díaz | Beatriz Alfaro-Trujillo | Manuel Guerrero-Gutiérrez | Arturo S Chayet-Berdowsky | R. Menchaca-Díaz | R. A. Cervantes-Castañeda | M. Guerrero-Gutiérrez | Beatriz Alfaro-Trujillo
[1] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[2] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[3] Diederick E. Grobbee,et al. The global burden of diabetes and its complications: an emerging pandemic , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[4] P. Zimmet,et al. The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[5] Enrique Villarreal-Ríos,et al. Prácticas preventivas de los habitantes mayores de 25 años en Monterrey y su zona metropolitana (México) , 2004 .
[6] D L DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.
[7] A. Arredondo,et al. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico. , 2005, Public health.
[8] R. B. Saldaña,et al. Conocimientos sobre diabetes mellitus en pacientes diabéticos tipo 2 tanto urbanos como rurales del occidente de México , 2007 .
[9] A. Prado-Serrano,et al. Prevalencia de retinopatía diabética en población mexicana , 2009 .
[10] Enrique Villarreal-Ríos,et al. Necesidades en salud del diabético usuario del primer nivel de atención , 2001 .
[11] A. Arredondo,et al. Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico , 2009, Diabetologia.
[12] Ann L. Albright,et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.
[13] L. Dandona,et al. Revision of visual impairment definitions in the International Statistical Classification of Diseases , 2006, BMC medicine.
[14] G. Roglić,et al. Mortality attributable to diabetes: estimates for the year 2010. , 2010, Diabetes research and clinical practice.
[15] J. Ruiz,et al. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2 en México: análisis de microcosteo , 2010 .
[16] Prevalencia de retinopatía diabética en pacientes con diabetes mellitus tipo 2 en Hidalgo, México , 2011 .
[17] Elvia Rodríguez-Villalobos,et al. Retinopatía diabética. Incidencia y progresión a 12 años , 2005 .
[18] A. Barcelo,et al. The cost of diabetes in Latin America and the Caribbean. , 2003, Bulletin of the World Health Organization.
[19] Efecto de una guía de práctica clínica para el manejo de la diabetes tipo 2 , 2007 .
[20] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[21] A. Arredondo,et al. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. , 2004, Diabetes care.
[22] S. Villalpando,et al. Diabetes mellitus en adultos mexicanos: resultados de la Encuesta Nacional de Salud 2000 , 2007 .